Showing results (51-60 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|December 9, 2024
Post-marketing safety of panitumumab: a real-world pharmacovigilance studyHeli Wen, Yuqing Lei, Lingjie MaoExpert Opinion on Drug Safety|December 22, 2024
Concomitant use of sodium-glucose co-transporter 2 inhibitors and metformin and the risk of osteomyelitis reporting: a disproportionality analysis based on FAERS databaseJiangfan Wu, Xin Wang, Xiaofang Zhao, et al.Expert Opinion on Drug Safety|December 24, 2024
Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)Yikuan Du, Mengting Zhang, Ziyi Luo, et al.Expert Opinion on Drug Safety|December 21, 2024
A real-world pharmacovigilance analysis for agalsidase beta: findings from the FDA adverse event reporting databaseWen-Long Xie, Hou-Hong Li, Di Li, et al.Expert Opinion on Drug Safety|December 23, 2024
Role of gliflozins on hepatocellular carcinoma progression: a systematic synthesis of preclinical and clinical evidenceLivia Basile, Rossella Cannarella, Paolo Magni, et al.Expert Opinion on Drug Safety|December 26, 2024
Severe cutaneous adverse reactions associated with antifungal agents: a pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) databaseHuifang Shan, Chunyan Wei, Jingyi Zhang, et al.Expert Opinion on Drug Safety|December 18, 2024
A real‑world pharmacovigilance study of raloxifene based on the FDA adverse event reporting system (FAERS)Hao Liu, Wei Yan, Di Luo, et al.Expert Opinion on Drug Safety|December 18, 2024
The antidepressants and sexual dysfunction: a pharmacovigilance-pharmacodynamic study of the FDA adverse event reporting systemYu Cheng, Youjun Chen, Xue Zhao, et al.Expert Opinion on Drug Safety|December 18, 2024
Pulmonary toxicity assessment of tumor necrosis factor α inhibitors in the treatment of IBD: a real world study based on US food and drug administration adverse events reporting system (FAERS)Sichen Sun, Xuan Shi, Mengling Ouyang, et al.Expert Opinion on Drug Safety|December 10, 2024
Oral anticoagulants-induced intracranial hemorrhage: a real-world pharmacovigilance study over 2008-2024Jiale Chen, Ling Wang, Guoquan Chen, et al.Pageof 281